API Suppliers
0
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
0
0
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
https://www.clinicaltrialsarena.com/news/laekna-prostate-cancer-trial/
https://www.prnewswire.com/news-releases/innovent-and-laekna-jointly-announce-first-patient-dosed-with-three-drug-combination-in-a-phase-12-study-for-the-treatment-of-patients-with-solid-tumors-who-were-resistant-to-prior-anti-pd-1pd-l1-therapy-301596506.html
https://www.clinicaltrialsarena.com/news/laekna-breast-cancer-trial/
https://www.prnewswire.com/news-releases/laekna-therapeutics-announces-dosing-of-first-patients-in-the-us-and-china-in-phase-ibiii-study-of-afuresertib-in-combination-with-fulvestrant-in-hrher2--breast-cancer-301555843.html
https://www.fiercebiotech.com/biotech/novartis-farms-out-rare-disease-drug-to-lifemax-labs